Navigation Links
Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results
Date:11/17/2009

trial for multiple myeloma
  • Richard Dondero, Vice President of Research & Development at Senesco, delivered the Company's corporate presentation at the 11th Annual Rodman & Renshaw Healthcare Conference
  • "SNS-01 continues to demonstrate potential as a possible treatment for multiple myeloma, most recently being the subject of a poster presentation at one of the most important oncology conferences of the year, the annual AACR-NCI-EORTC Conference," said Jack Van Hulst, President and Chief Executive Officer of Senesco.

    The Company did not record any revenue for the three month period ended September 30, 2009. Total revenues of $200,000 for the three month period ended September 30, 2008 consisted of a milestone payment in connection with an agricultural license agreement.

    Research and development expenses during the three month period ended September 30, 2009 were $575,291, compared with $504,386 during the three month period ended September 30, 2008, an increase of 14.1%. This increase was primarily a result of an $89,000 loss on the extinguishment of debt in connection with the issuance of common stock and warrants to Cato Holding Company in exchange for debt that was owed by Senesco to Cato Research Ltd. in the amount of $175,000, which was slightly offset by decrease in the cost of the research performed at the University of Waterloo as a result of the stronger U.S. dollar against the Canadian dollar.

    General and administrative expenses were $494,955 for the three month period ended September 30, 2009, compared with $529,865 during the three month period ended September 30, 2008, a decrease of 6.6%. This decrease was due primarily to a $34,000 decrease in stock based compensation, and a $20,000 decrease in professional fees, which were a result of a decrease in legal and accounting fees related to the review of our securities filings. These decreases were slightly offset by a $15,000 i
    '/>"/>

    SOURCE Senesco Technologies, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
    2. Senesco Announces H1N1 Influenza Survival Test Results in Mice
    3. Senesco Chooses VGXI to Produce Factor 5A Plasmid
    4. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
    5. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
    6. Senesco Technologies Initiates Preclinical Studies for Cancer Target
    7. EF Johnson Technologies Announces Third Quarter Results
    8. Ionian Technologies, Inc. Signs Molecular Diagnostic Manufacturing Agreement With Roche Diagnostics
    9. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
    10. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
    11. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... 28, 2015 , Joint research by ... from Biostar , Published in ,Stem Cells Translational ... lifespan through multiple IV administration of Adipose-derived MSC ... expectancy found , Commercialization within 5 years expected ... possibility that adult mesenchymal stem cells (MSCs) may extend ...
    (Date:8/28/2015)... SAN FRANCISCO , August 28, 2015 ... is expected to reach USD 49.12 billion by 2020, ... 2020, according to a new report by Grand View ... an estimated CAGR of 49.7% from 2014 to 2020. ... Growing aging population along with rising incidences of ...
    (Date:8/27/2015)... Aug. 27, 2015 Biosimilars are not ... the U.S. Food and Drug Administration (FDA) for ... in its draft guidance issued today. The FDA,s ... proposes distinguishable names, calling for biological products to ... suffix. This proposal reflects the agency,s thinking that ...
    Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2
    ... Lytle LLP, one of the region,s best known law ... Court in Rochester, upheld a high-profile products liability verdict ... In its decision, the Fourth Department judicial panel found ... of Cheektowaga, NY a quadriplegic.  In making its findings, ...
    ... 18, 2011 The U.S. Food and Drug Administration ... (neovascular) age-related macular degeneration (AMD), a leading cause of ... older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... affects the macula, the part of the eye that ...
    Cached Medicine Technology:The Appellate Division of State Supreme Court has Upheld a Landmark 2010 Products Liability Verdict Which Found Cybex International Responsible for Catastrophic Injuries Suffered by a Cheektowaga Woman 2The Appellate Division of State Supreme Court has Upheld a Landmark 2010 Products Liability Verdict Which Found Cybex International Responsible for Catastrophic Injuries Suffered by a Cheektowaga Woman 3FDA Approves Eylea for Eye Disorder in Older People 2
    (Date:8/28/2015)... ... August 28, 2015 , ... Drugs and alcohol ... Strawbridge, gives a new approach on solutions in his new book ":Unraveling The ... and employees getting together for meaningful group meetings. "This would educate the employees ...
    (Date:8/28/2015)... ... August 28, 2015 , ... The ... honoring military veterans leading in business. Mr. Troy Mizell, Chairman of the ... inaugural Nashville Business Journal's 2015 Veterans Awards will recognize Nashville military veterans who, ...
    (Date:8/28/2015)... ... ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with back pain ... pain, neck pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan received his ... on to earn his title of Doctor of Chiropractic from the Palmer College of ...
    (Date:8/28/2015)... ... 28, 2015 , ... The Quatela Center for Plastic Surgery is excited to ... nonsurgical product approved by the Food and Drug Administration to eliminate submental fat, also ... William Koenig are among the premier cosmetic surgeons in Rochester to offer this ...
    (Date:8/28/2015)... ... August 28, 2015 , ... Mendon, IL, home of the Adams County ... people, all for a good cause. In its second year, the “Music With A ... Best Drug Rehabilitation. The “Mission” of “Music With A Mission” is to raise money ...
    Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2
    ... Former NFL player and Dallas Cowboy,Jason Kaiser received top ... Kaiser earned the title of,valedictorian with a GPA of ... school and in my class especially," he said. "To ... in Parker College, Kaiser played professional football,for more than ...
    ... less blood loss, shorter hospital stays, study finds , , ... surgery to remove pancreatic tumors or cysts leads to ... finds. , In laparoscopic surgery, doctors make smaller ... with fiber optics and video cameras. This less invasive ...
    ... - QLT Inc. (NASDAQ: QLTI;,TSX: QLT) today reported financial ... specified otherwise, all amounts are in U.S. dollars,and in ... of 2008, we were pleased to report the U.S. ... for blood,monitoring from the Aczone(TM) label," said Bob Butchofsky, ...
    ... MAPP ) today announced that the company will,present at ... 2008:, Morgan Stanley Global Healthcare Conference, Key Biscayne, ... Time, Deutsche Bank 33rd Annual Health Care Conference, Boston, ... Time A live webcast of the presentations will be ...
    ... HILL, N.C., April 25 Managing multi-generational,diversity is ... recent,benchmarking study with 23 leading companies, 80 percent ... and yet only one-third say,their companies offer training ... to download an excerpt of,this new research, The ...
    ... Today, on World Malaria,Day, the American Red Cross is ... robust global response to this deadly disease., Each ... 300 million people, mostly children in Africa. More,than 1 ... Since 2001, the American Red Cross and its ...
    Cached Medicine News:Health News:Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate 2Health News:Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate 3Health News:Laparoscopic Surgery on Pancreas Has Fewer Complications 2Health News:QLT announces first quarter results for 2008 2Health News:QLT announces first quarter results for 2008 3Health News:QLT announces first quarter results for 2008 4Health News:QLT announces first quarter results for 2008 5Health News:QLT announces first quarter results for 2008 6Health News:QLT announces first quarter results for 2008 7Health News:QLT announces first quarter results for 2008 8Health News:QLT announces first quarter results for 2008 9Health News:QLT announces first quarter results for 2008 10Health News:QLT announces first quarter results for 2008 11Health News:QLT announces first quarter results for 2008 12Health News:QLT announces first quarter results for 2008 13Health News:QLT announces first quarter results for 2008 14Health News:MAP Pharmaceuticals to Present at Upcoming Investor Conferences 2Health News:Multi-generational Diversity Top Challenge for Businesses Today: Leading Company to Share Insights June 4-6 2Health News:Uniting to Fight Malaria Around the World 2Health News:Uniting to Fight Malaria Around the World 3
    Two prong stainless steel tips; with titanium handle/...
    Straight shaft with fine pointed 0.3mm Tips for Grasping Delicate Capsule; In Titanium....
    12mm from bend to 0.12mm 1x2 teeth; In Titanium....
    Straight Shafts with 0.12mm 1X2 Teeth With 5mm Tying Platform; In Titanium...
    Medicine Products: